SCOPUS 정보 검색 플랫폼

Volumn 28, Issue 24, 2010, Pages

CNS relapse in acute promyeloctyic leukemia

(9) Housman, Elizabeth a Chang, Priscilla b Lane, Steven W b Blinder, Russell b Galinsky, Ilene c Kesari, Santosh c Ho, Vincent T c Stone, Richard M c Mullally, Ann c

a BOSTON UNIVERSITY SCHOOL OF MEDICINE (United States)

b BRIGHAM AND WOMEN S HOSPITAL (United States)

c HARVARD MEDICAL SCHOOL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID; ANTINEOPLASTIC AGENT; CD135 ANTIGEN; FLT3 PROTEIN, HUMAN; NUCLEAR PROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PML PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; FEMALE; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TREATMENT OUTCOME; AUTOTRANSPLANTATION; BONE MARROW CANCER; BRAIN TUMOR; CHROMOSOME 15; CHROMOSOME 17; DRUG ADMINISTRATION; GENE TRANSLOCATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RECURRENT DISEASE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKULL IRRADIATION;

6-MERCAPTOPURINE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; BONE MARROW NEOPLASMS; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; CRANIAL IRRADIATION; CYTARABINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FMS-LIKE TYROSINE KINASE 3; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; METHOTREXATE; MUTATION; NUCLEAR PROTEINS; OXIDES; RECEPTORS, RETINOIC ACID; RECURRENCE; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 77956256990 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2009.27.1577 Document Type: Article

Times cited : (6)

References (20)

1
- 0034663162
- Definition of relapse risk and role of nonanthracycline drags for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups
- Sanz MA, Lo Coco F, Martín G, et al: Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96:1247-1253, 2000 (Pubitemid 30658450)
- (2000) Blood , vol.96 , Issue.4 , pp. 1247-1253
- Sanz, M.A.¹ Lo, C.F.² Martin, G.³ Avvisati, G.⁴ Rayon, C.⁵ Barbui, T.⁶ Diaz-Mediavilla, J.⁷ Fioritoni, G.⁸ Gonzalez, J.D.⁹ Liso, V.¹⁰ Esteve, J.¹¹ Ferrara, F.¹² Bolufer, P.¹³ Bernasconi, C.¹⁴ Gonzalez, M.¹⁵ Rodeghiero, F.¹⁶ Colomer, D.¹⁷ Petti, M.C.¹⁸ Ribera, J.M.¹⁹ Mandelli, F.²⁰ more..

2
- 10744220024
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: A multicenter study by the PETHEMA group
- DOI 10.1182/blood-2003-07-2462
- Sanz MA, Martín G, Gonzalez M, et al: Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: A multicenter study by the PETHEMA group. Blood 103:1237-1243, 2004 (Pubitemid 38168633)
- (2004) Blood , vol.103 , Issue.4 , pp. 1237-1243
- Sanz, M.A.¹ Martin, G.² Gonzalez, M.³ Leon, A.⁴ Rayon, C.⁵ Rivas, C.⁶ Colomer, D.⁷ Amutio, E.⁸ Capote, F.J.⁹ Milone, G.A.¹⁰ De, L.S.J.¹¹ Roman, J.¹² Barragan, E.¹³ Bergua, J.¹⁴ Escoda, L.¹⁵ Parody, R.¹⁶ Negri, S.¹⁷ Calasanz, M.J.¹⁸ Bolufer, P.¹⁹

3
- 35348849758
- Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710
- suppl; abstr 2
- Powell BL: Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710. J Clin Oncol 25:1s, 2007 (suppl; abstr 2)
- (2007) J Clin Oncol , vol.25
- Powell, B.L.¹

4
- 0032487923
- Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
- DOI 10.1056/NEJM199811053391901
- Soignet SL, Maslak P, Wang ZG, et al: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341-1348, 1998 (Pubitemid 28509343)
- (1998) New England Journal of Medicine , vol.339 , Issue.19 , pp. 1341-1348
- Soignet, S.L.¹ Maslak, P.² Wang, Z.-G.³ Jhanwar, S.⁴ Calleja, E.⁵ Dardashti, L.J.⁶ Corso, D.⁷ DeBlasio, A.⁸ Gabrilove, J.⁹ Scheinberg, D.A.¹⁰ Pandolfi, P.P.¹¹ Warrell Jr., R.P.¹²

5
- 0035884639
- United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
- Soignet SL, Frankel SR, Douer D, et al: United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 19:3852-3860, 2001 (Pubitemid 32880064)
- (2001) Journal of Clinical Oncology , vol.19 , Issue.18 , pp. 3852-3860
- Soignet, S.L.¹ Frankel, S.R.² Douer, D.³ Tallman, M.S.⁴ Kantarjian, H.⁵ Calleja, E.⁶ Stone, R.M.⁷ Kalaycio, M.⁸ Scheinberg, D.A.⁹ Steinherz, P.¹⁰ Sievers, E.L.¹¹ Coutre, S.¹² Dahlberg, S.¹³ Ellison, R.¹⁴ Warrell Jr., R.P.¹⁵

6
- 0034046084
- Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation
- Thomas X, Dombret H, Cordonnier C, et al: Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia Leukemia 14:1006-1013, 2000 (Pubitemid 30389504)
- (2000) Leukemia , vol.14 , Issue.6 , pp. 1006-1013
- Thomas, X.¹ Dombret, H.² Cordonnier, C.³ Pigneux, A.⁴ Gardin, C.⁵ Guerci, A.⁶ Vekhoff, A.⁷ Sadoun, A.⁸ Stamatoullas, A.⁹ Fegueux, N.¹⁰ Maloisel, F.¹¹ Cahn, J.Y.¹² Reman, O.¹³ Gratecos, N.¹⁴ Berthou, C.¹⁵ Huguet, F.¹⁶ Kotoucek, P.¹⁷ Travade, P.¹⁸ Buzyn, A.¹⁹ De, R.T.²⁰ more..

7
- 0030741745
- Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: Prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene
- Meloni G, Diverio D, Vignetti M, et al: Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: Prognostic relevance of pretransplant minimal residual disease assessment by reversetranscription polymerase chain reaction of the PML/RAR alpha fusion gene. Blood 90:1321-1325, 1997 (Pubitemid 27314172)
- (1997) Blood , vol.90 , Issue.3 , pp. 1321-1325
- Meloni, G.¹ Diverio, D.² Vignetti, M.³ Avvisati, G.⁴ Capria, S.⁵ Petti, M.C.⁶ Mandelli, F.⁷ Lo, C.F.⁸

8
- 11144355810
- 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia
- DOI 10.1073/pnas.0400053101
- Shen ZX, Shi ZZ, Fang J, et al: All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A 101:5328-5335, 2004 (Pubitemid 38481160)
- (2004) Proceedings of the National Academy of Sciences of the United States of America , vol.101 , Issue.15 , pp. 5328-5335
- Shen, Z.-X.¹ Shi, Z.-Z.² Fang, J.³ Gu, B.-W.⁴ Li, J.-M.⁵ Zhu, Y.-M.⁶ Shi, J.-Y.⁷ Zheng, P.-Z.⁸ Yan, H.⁹ Liu, Y.-F.¹⁰ Chen, Y.¹¹ Shen, Y.¹² Wu, W.¹³ Tang, W.¹⁴ Waxman, S.¹⁵ De, T.H.¹⁶ Wang, Z.-Y.¹⁷ Chen, S.-J.¹⁸ Chen, Z.¹⁹

9
- 59149089411
- Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin
- Ravandi F, Estey E, Jones D, et al: Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. J Clin Oncol 27:504-510, 2009
- (2009) J Clin Oncol , vol.27 , pp. 504-510
- Ravandi, F.¹ Estey, E.² Jones, D.³

10
- 39349106820
- Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Update on defibrotide and other current investigational therapies
- DOI 10.1038/sj.bmt.1705899, PII 1705899
- Ho VT, Revta C, Richardson PG: Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Update on defibrotide and other current investigational therapies. Bone Marrow Transplant 41:229-237, 2008 (Pubitemid 351260376)
- (2008) Bone Marrow Transplantation , vol.41 , Issue.3 , pp. 229-237
- Ho, V.T.¹ Revta, C.² Richardson, P.G.³

11
- 34547802157
- Hematopoietic Cell Transplantation in Acute Promyelocytic Leukemia: A Comprehensive Review
- DOI 10.1016/j.bbmt.2007.05.005, PII S1083879107002753
- Kharfan-Dabaja MA, Abou Mourad YR, Fernandez HF, et al: Hematopoietic cell transplantation in acute promyelocytic leukemia: A comprehensive review. Biol Blood Marrow Transplant 13:997-1004, 2007 (Pubitemid 47240750)
- (2007) Biology of Blood and Marrow Transplantation , vol.13 , Issue.9 , pp. 997-1004
- Kharfan-Dabaja, M.A.¹ Abou, M.Y.R.² Fernandez, H.F.³ Pasquini, M.C.⁴ Santos, E.S.⁵

12
- 84989920257
- The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment
- Lo-Coco F, Ammatuna E: The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Hematology Am Soc Hematol Educ Program 156-61, 514, 2006
- (2006) Hematology Am Soc Hematol Educ Program , vol.514 , pp. 156-161
- Lo-Coco, F.¹ Ammatuna, E.²

13
- 0036850573
- Alterations of the FLT3 gene in acute promyelocytic leukemia: Association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol
- DOI 10.1038/sj.leu.2402723
- Noguera NI, Breccia M, Divona M, et al: Alterations of the FLT3 gene in acute promyelocytic leukemia: Association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia 16:2185-2189, 2002 (Pubitemid 35331832)
- (2002) Leukemia , vol.16 , Issue.11 , pp. 2185-2189
- Noguera, N.I.¹ Breccia, M.² Divona, M.³ Diverio, D.⁴ Costa, V.⁵ De, S.S.⁶ Avvisati, G.⁷ Pinazzi, M.B.⁸ Petti, M.C.⁹ Mandelli, F.¹⁰ Lo, C.F.¹¹

14
- 28444485658
- Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia
- DOI 10.1182/blood-2005-04-1746
- Gale RE, Hills R, Pizzey AR, et al: Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood 106:3768-3776, 2005 (Pubitemid 41739011)
- (2005) Blood , vol.106 , Issue.12 , pp. 3768-3776
- Gale, R.E.¹ Hills, R.² Pizzey, A.R.³ Kottaridis, P.D.⁴ Swirsky, D.⁵ Gilkes, A.F.⁶ Nugent, E.⁷ Mills, K.I.⁸ Wheatley, K.⁹ Solomon, E.¹⁰ Burnett, A.K.¹¹ Linch, D.C.¹² Grimwade, D.¹³

15
- 33644976445
- Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
- de Botton S, Sanz MA, Chevret S, et al: Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 20:35-41, 2006
- (2006) Leukemia , vol.20 , pp. 35-41
- De Botton, S.¹ Sanz, M.A.² Chevret, S.³

16
- 0035886697
- Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto
- Specchia G, Lo Coco F, Vignetti M, et al: Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol 19:4023-4028, 2001 (Pubitemid 32976688)
- (2001) Journal of Clinical Oncology , vol.19 , Issue.20 , pp. 4023-4028
- Specchia, G.¹ Lo, C.F.² Vignetti, M.³ Avvisati, G.⁴ Fazi, P.⁵ Albano, F.⁶ Di, R.F.⁷ Martino, B.⁸ Ferrara, F.⁹ Selleri, C.¹⁰ Liso, V.¹¹ Mandelli, F.¹²

17
- 0033858433
- Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: Effects in patients with newly diagnosed acute promyelocytic leukemia
- Lengfelder E, Reichert A, Schoch C, et al: Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: Effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group. Leukemia 14:1362-1370, 2000 (Pubitemid 30601354)
- (2000) Leukemia , vol.14 , Issue.8 , pp. 1362-1370
- Lengfelder, E.¹ Reichert, A.² Schoch, C.³ Haase, D.⁴ Haferlach, T.⁵ Loffler, H.⁶ Staib, P.⁷ Heyll, A.⁸ Seifarth, W.⁹ Saussele, S.¹⁰ Fonatsch, C.¹¹ Gassmann, W.¹² Ludwig, W.-D.¹³ Hochhaus, A.¹⁴ Beelen, D.¹⁵ Aul, C.¹⁶ Sauerland, M.-C.¹⁷ Heinecke, A.¹⁸ Hehlmann, R.¹⁹ Wormann, B.²⁰ Hiddemann, W.²¹ Buchner, T.²² more..

18
- 55749109523
- Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy
- Au WY, Tam S, Fong BM, et al: Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy. Blood 112:3587-3590, 2008
- (2008) Blood , vol.112 , pp. 3587-3590
- Au, W.Y.¹ Tam, S.² Fong, B.M.³

19
- 62549083523
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- Hu J, Liu YF, Wu CF, et al: Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A 106:3342-3347, 2009
- (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 3342-3347
- Hu, J.¹ Liu, Y.F.² Wu, C.F.³

20
- 73949097021
- How I treat acute promyelocytic leukemia
- Tallman MS, Altman JK: How I treat acute promyelocytic leukemia. Blood 114:5126-5135, 2009
- (2009) Blood , vol.114 , pp. 5126-5135
- Tallman, M.S.¹ Altman, J.K.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.